売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2025/12 |
200,925 |
79.6%
|
| 2024/12 |
167,178 |
79.0%
|
| 2023/12 |
138,886 |
78.8%
|
| 2022/12 |
106,409 |
85.2%
|
| 2021/12 |
90,152 |
88.4%
|
| 2020/12 |
73,387 |
|
| 2019/12 |
67,301 |
|
| 2018/12 |
55,380 |
|
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2025/12 |
-22,330 |
-11.1%
|
| 2024/12 |
-35,248 |
-21.1%
|
| 2023/12 |
-46,931 |
-33.8%
|
| 2022/12 |
-59,609 |
-56.0%
|
| 2021/12 |
-51,670 |
-57.3%
|
| 2020/12 |
-38,567 |
|
| 2019/12 |
-36,003 |
|
| 2018/12 |
-11,965 |
|
|
（単位：千ドル）
|
2018/12
|
2019/12
|
2020/12
|
2021/12
|
2022/12
|
2023/12
|
2024/12
|
2025/12
|
|
売上高
|
55,380
|
67,301
|
73,387
|
90,152
|
106,409
|
138,886
|
167,178
|
200,925
|
|
売上成長率（％）
|
-
|
|
|
22.8
|
18.0
|
30.5
|
20.4
|
20.2
|
|
売上原価
|
4,833
|
6,790
|
8,902
|
10,428
|
15,705
|
29,466
|
35,057
|
41,046
|
|
売上総利益
|
50,547
|
60,511
|
64,485
|
79,724
|
90,704
|
109,420
|
132,121
|
159,879
|
|
売上総利益率（％）
|
|
|
|
88.4
|
85.2
|
78.8
|
79.0
|
79.6
|
|
研究開発費
|
5,376
|
7,279
|
9,459
|
12,441
|
13,627
|
15,028
|
16,560
|
17,448
|
|
営業費用
|
62,512
|
96,514
|
103,052
|
131,394
|
150,313
|
156,351
|
167,369
|
182,209
|
|
営業利益
|
-11,965
|
-36,003
|
-38,567
|
-51,670
|
-59,609
|
-46,931
|
-35,248
|
-22,330
|
|
営業利益率 (%)
|
|
|
|
-57.3
|
-56.0
|
-33.8
|
-21.1
|
-11.1
|
|
純利益
|
-17,453
|
-38,403
|
-43,700
|
-56,572
|
-61,256
|
-43,336
|
-30,913
|
-18,904
|
|
純利益率（％）
|
|
|
|
-62.8
|
-57.6
|
-31.2
|
-18.5
|
-9.4
|
|
一株あたり利益
|
-
|
-
|
-
|
-1.71
|
-1.79
|
-1.13
|
-0.75
|
-0.44
|
|
希薄化後一株あたり利益
|
-
|
-
|
-
|
-1.71
|
-1.79
|
-1.13
|
-0.75
|
-0.44
|
|
一株あたり配当金
|
0
|
0
|
-
|
-
|
-
|
-
|
-
|
-
|
|
EBITDA
|
|
|
|
-49,584
|
-56,157
|
-41,503
|
-30,869
|
-16,560
|
|
EBITDAマージン（％）
|
|
|
|
-55.0
|
-52.8
|
-29.9
|
-18.5
|
-8.2
|